Self-Administered Parenteral Global Market Report 2025

Description

Self-administered parenteral refers to the practice of administering medication or ssubstances directly into the body through injection methods by the individual themselves. This approach grants patients increased independence and convenience, enabling them to manage their conditions in a flexible and comfortable manner without frequent visits to healthcare facilities.

The primary products in self-administered parenterals include pre-filled syringes, autoinjectors, pen injectors, and others. Pre-filled syringes are pre-loaded medical devices designed for the delivery of liquid medications. They are available as both disposable and reusable options and are distributed through various channels including hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, among others. These products are utilized in the treatment of conditions such as cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement therapy, and others.

The self-administered parenteral market research report is one of a series of new reports from The Business Research Company that provides self-administered parenteral market statistics, including self-administered parenteral industry global market size, regional shares, competitors with a self-administered parenteral market share, detailed self-administered parenteral market segments, market trends and opportunities, and any further data you may need to thrive in the self-administered parenteral industry. This self-administered parenteral market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-administered parenteral market size has grown strongly in recent years. It will grow from $24.57 billion in 2024 to $26.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in chronic diseases, aging population, government initiatives, patient education and support programs, the rising incidences of bone disorders.

The self-administered parenteral market size is expected to see steady growth in the next few years. It will grow to $31.18 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing patient preference for home healthcare, telemedicine and remote patient monitoring, patient education and support initiatives, growing personalized medicine. Major trends in the forecast period include integration of digital health solutions, customized drug delivery systems, emergence of targeted therapies, advancements in biologics.

The projected rise in chronic diseases is anticipated to drive the expansion of the self-administered parenteral market in the future. Chronic diseases are enduring medical conditions characterized by slow progression and necessitate ongoing management and treatment. Self-administered parenteral products play a crucial role in managing chronic diseases by enabling individuals to independently administer treatment, thereby significantly enhancing adherence compared to oral medication. For instance, data from the National Institutes of Health in January 2023 revealed that among individuals aged 50 or older, the prevalence of at least one chronic disease is expected to surge by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the escalating incidence of chronic diseases serves as a key driver fueling the growth of the self-administered parenteral market.

Major players in the self-administered parenteral market are concentrating on the development of innovative products such as the UDENYCA autoinjector to enhance patient choice and control, thereby improving treatment accessibility. An autoinjector is a medical device engineered to deliver a single dose of a specific drug, featuring an intuitive design where administration is triggered immediately and reliably by push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech company, introduced the UDENYCA autoinjector, a self-administered parenteral medication in the US market. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector offering patients an additional administration option for pegfilgrastim. Its intuitive design, activated by push-on-skin, ensures reliable and immediate delivery of a full pegfilgrastim dose. Moreover, it incorporates various user-friendly features such as rapid dosing, intuitive design, dual coverage for at-home and in-office use, and a reduction in the risk of febrile neutropenia, thereby enhancing the overall treatment experience.

In May 2022, Halozyme Therapeutics Inc., a biotechnology company headquartered in the United States, finalized the acquisition of Antares Pharma Inc. for $960 million. Through this transaction, Halozyme aims to leverage Antares' foundational platform technologies and capabilities, intending to establish a leading specialty product and medicine delivery company by expanding its portfolio in this sector. Antares Pharma Inc., also based in the US, specializes in the manufacturing of self-administered parenteral medications.

Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-administered parenteral market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self-administered parenteral market consists of sales of biologic drugs, blood thinners, fertility drugs, osteoporosis medications, and insulin and inhaler devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Administered Parenteral Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-administered parenteral market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-administered parenteral ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The self-administered parenteral market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Pre-Filled Syringes; Autoinjectors; Pen Injectors; Other Products
2) By Usage: Disposable; Reusable
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Home Healthcare Providers; Specialty Clinics; Other Distribution Channels
4) By Application: Cardiovascular Diseases; Diabetes; Osteoporosis; Pain Management; Hormone Replacement; Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes; Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors; Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors; Growth Hormone Pen Injectors; Other Pen Injectors
4) By Other Products: Infusion Pumps; Needle-Free Injectors; Combination Devices
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28955

1. Executive Summary

2. Self-Administered Parenteral Market Characteristics

3. Self-Administered Parenteral Market Trends And Strategies

4. Self-Administered Parenteral Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Self-Administered Parenteral Growth Analysis And Strategic Analysis Framework

5.1. Global Self-Administered Parenteral PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Self-Administered Parenteral Market Growth Rate Analysis
5.4. Global Self-Administered Parenteral Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Self-Administered Parenteral Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Self-Administered Parenteral Total Addressable Market (TAM)

6. Self-Administered Parenteral Market Segmentation

6.1. Global Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Filled Syringes
Autoinjectors
Pen Injectors
Other Products
6.2. Global Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disposable
Reusable
6.3. Global Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Online Pharmacies
Home Healthcare Providers
Specialty Clinics
Other Distribution Channels
6.4. Global Self-Administered Parenteral Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases
Diabetes
Osteoporosis
Pain Management
Hormone Replacement
Other Applications
6.5. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pre-Filled Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glass Pre-Filled Syringes
Plastic Pre-Filled Syringes
6.6. Global Self-Administered Parenteral Market, Sub-Segmentation Of Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disposable Autoinjectors
Reusable Autoinjectors
6.7. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insulin Pen Injectors
Growth Hormone Pen Injectors
Other Pen Injectors
6.8. Global Self-Administered Parenteral Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infusion Pumps
Needle-Free Injectors
Combination Devices

7. Self-Administered Parenteral Market Regional And Country Analysis

7.1. Global Self-Administered Parenteral Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Self-Administered Parenteral Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Administered Parenteral Market

8.1. Asia-Pacific Self-Administered Parenteral Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Administered Parenteral Market

9.1. China Self-Administered Parenteral Market Overview
9.2. China Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Administered Parenteral Market

10.1. India Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Administered Parenteral Market

11.1. Japan Self-Administered Parenteral Market Overview
11.2. Japan Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Administered Parenteral Market

12.1. Australia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Administered Parenteral Market

13.1. Indonesia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Administered Parenteral Market

14.1. South Korea Self-Administered Parenteral Market Overview
14.2. South Korea Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Administered Parenteral Market

15.1. Western Europe Self-Administered Parenteral Market Overview
15.2. Western Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Administered Parenteral Market

16.1. UK Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Administered Parenteral Market

17.1. Germany Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Administered Parenteral Market

18.1. France Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Administered Parenteral Market

19.1. Italy Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Administered Parenteral Market

20.1. Spain Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Administered Parenteral Market

21.1. Eastern Europe Self-Administered Parenteral Market Overview
21.2. Eastern Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Administered Parenteral Market

22.1. Russia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Administered Parenteral Market

23.1. North America Self-Administered Parenteral Market Overview
23.2. North America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Administered Parenteral Market

24.1. USA Self-Administered Parenteral Market Overview
24.2. USA Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Administered Parenteral Market

25.1. Canada Self-Administered Parenteral Market Overview
25.2. Canada Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Administered Parenteral Market

26.1. South America Self-Administered Parenteral Market Overview
26.2. South America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Administered Parenteral Market

27.1. Brazil Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Administered Parenteral Market

28.1. Middle East Self-Administered Parenteral Market Overview
28.2. Middle East Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Administered Parenteral Market

29.1. Africa Self-Administered Parenteral Market Overview
29.2. Africa Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Administered Parenteral Market Competitive Landscape And Company Profiles

30.1. Self-Administered Parenteral Market Competitive Landscape
30.2. Self-Administered Parenteral Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Self-Administered Parenteral Market Other Major And Innovative Companies

31.1. Roche Holding AG
31.2. Eli Lilly and Company
31.3. Novo Nordisk A/S
31.4. Becton, Dickinson and Company
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Mylan N.V.
31.7. Terumo Corporation
31.8. Catalent Inc.
31.9. Dexcom Inc.
31.10. West Pharmaceutical Services Inc.
31.11. Gerresheimer AG
31.12. Biocon Limited
31.13. Insulet Corporation
31.14. Halozyme Therapeutics Inc.
31.15. Ypsomed AG

32. Global Self-Administered Parenteral Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Administered Parenteral Market

34. Recent Developments In The Self-Administered Parenteral Market

35. Self-Administered Parenteral Market High Potential Countries, Segments and Strategies

35.1 Self-Administered Parenteral Market In 2029 - Countries Offering Most New Opportunities
35.2 Self-Administered Parenteral Market In 2029 - Segments Offering Most New Opportunities
35.3 Self-Administered Parenteral Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer